Forscher des Helmholtz Zentrums München haben beobachtet, dass bei bestimmten Subtypen einer COPD Veränderungen des Mikrobioms in der Lunge auftreten, die die Ansiedlung potenziell krankheitserregender Keime begünstigen können ( … lesen Sie weiter! Quelle: : http://www.aerztezeitung.de/medizin/krankheiten/asthma/article/939999/forschung-copd-veraendert-mikrobiom-lunge.html
Related Posts
Mukoviszidose: Tipps bei chronischer Infektion mit Pseudomonas
Die S3-Leitlinie „Lungenerkrankung bei Mukoviszidose Modul 2: Diagnostik und Therapie bei chronischer Infektion mit Pseudomonas aeruginosa“ (AWMF Registernummer 020 – 018; Stand 1.7. 2017, gültig bis 30.6. 2022) steht online. … lesen Sie weiter! Quelle: : http://www.aerztezeitung.de/medizin/krankheiten/infektionskrankheiten/article/958232/mukoviszidose-tipps-chronischer-infektion-pseudomonas.html
INTERVIEW: Daniel Kraft of FutureMed – PART 3
This is the 3rd and final part of an interview with Dr. Daniel Kraft, Executive Director of FutureMed at the Singularity University; conducted on the 31st of October 2012 at the Pioneers Festival in Vienna, Austria. The first part of our interview with Dr. Kraft is available here and the second part here. Be sure to catch Dr. Kraft’s talk at the Pioneers Festival in which he shares some of his views and insights into Hacking the Human Body and what he foresaw could be the Future of Medicine. In this final part of our interview Daniel Kraft in confronted with the following questions and responds with some very insightful answers: Which areas of medicine would best benefit from an entrepreneurial mindset? Are doctors “natural born hackers”? Where can social-media be applied in medicine? You can follow Daniel Kraft on Twitter at https://twitter.com/daniel_kraft
What To Do If You Have Trouble Filling Your EpiPen® or Generic Epinephrine Prescription
We have heard from members in our community that many are having trouble filling prescriptions for three of the four types of epinephrine auto-injectors: EpiPen® and EpiPen Jr® (distributed by Mylan) The authorized generic of EpiPen® and EpiPen Jr® (distributed